ILLR Announces Successful Completion of Merger-Related Restructuring, Filings of 2024 10-K and three 2025 10-Qs, and Robust Compliance Framework

Triller Group Inc (Nasdaq: ILLR; ILLRW) (“Triller” or the “Company”) announced the successful completion of its comprehensive ...

Triller Group Inc.: ILLR Announces Successful Completion of Merger-Related Restructuring, Filings of 2024 10-K and three 2025 10-Qs, and Robust Compliance Framework

Triller Group Inc (Nasdaq: ILLR; ILLRW) ("Triller" or the "Company") announced the successful completion of its comprehensive post-merger restructuring ...
The Manila Times

Raymond James Financial Reports Fiscal First Quarter of 2026 Results

Raymond James Financial, Inc. (NYSE: RJF) today reported net revenues of $3.74 billion and net income available to common shareholders of $562 million, or $2.79 per diluted share, for the fiscal first ...

Some people are born with a speed advantage—but anyone can become a faster runner. Here's how.

New PRs, ahead.

Johnson & Johnson: DARZALEX FASPRO-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible

Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care?